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馬　  瀬  　新　太　郎
　サイトカイン誘導キラー (cytokine-induced killer，CIK) 細胞は，生体外で増殖させたリンパ球で，ナチュラル
キラー (natural killer， NK) 細胞およびT細胞マーカーの両方を発現する．造血幹細胞移植においてCIK細胞の養
子輸注は，NK細胞上の活性化受容体であるNKG2Dを介した抗腫瘍活性を示しつつ，移植片対宿主病 (graft-
versus-host-disease，GVHD) を非致死的に留めることが報告されている．しかし、その機序はまだ完全には解明
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dendritic cell; GVHD，graft-versus-host disease; IFN-γ，interferon-γ; IL-2，interleukin-2; KO，knockout; NK，
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　C57BL/6 (B6，H-2b)，Balb/c (H-2d) マウスは日本
チャールスリバーから購入し野生型 (wild type，WT) と
して使用した．B6背景のIFN-γ KOマウスは岩倉洋一郎




ン名 ; 145-2C11)，CD11c (N418)，B220 (RA3-6B2)，Gr-1 
(RB6-8C5)，NKG2D (DEX5)，H-2Kb (AF6-88.5)，H-2Kd 












(Biolegend) を1000 U/mlの濃度で添加し，5％ CO2存在
下に37℃で培養した．24時間後，抗CD3抗体 (BD 
Bioscience) を付着させたフラスコに移し，リコンビナン














養液を10 ml 加えた (図1)．培養10日目に非接着細胞を
採取し，洗浄後，これを以下の実験に使用した．なお，
培養 10日目には，90％以上の細胞がDC (CD11c＋MHC 
Class II＋) の表現型を示した．
Fig. 1.  Expansion of CIK cells and generation of dendritic cells 
(DCs).
 CIK cells were expanded ex vivo as follows. Splenocytes were 
isolated from C57BL/6 (B6) mice and cultured in RPMI-1640 
medium with 10% FBS in the presence of IFN-γ at 300 IU/ml. 
After 24 hrs of culture, the cells were transferred to a plastic 
flask coated with anti-CD3 monoclonal antibody and the 
culture was continued with recombinant human IL-2 at 300 IU/
ml. For the generation of DCs, 2 x 106 bone marrow (BM) cells 
from B6 mice or Balb/c (H-2d) mice were cultured in 10 ml 
RPMI-1640 supplemented with GM-CSF at 20 ng/ml. On day 3, 
6 and 8, GM-CSF was further added and non-adherent DCs 
were harvested on day 10. More than 90% of the harvested 
cells expressed phenotype characteristic of DCs (CD11c＋ 
MHC class II＋).
Fig. 2.  Compositions of CIK cells.
 Within the bulk culture of expanded CIK cells, two main 
subpopulations can be distinguished, one co-expressing the 
CD8 and NKG2D molecules (CD8＋NKG2D＋) while the other 
presenting a CD8＋NKG2D－ phenotype. The majority of 
expanded CIK cells are CD8＋ but CD4＋CD8– cells can be found 
as well. Double positive (CD4＋CD8＋) or double negative (CD4–


















リッヒジャパン，東京 ) 100 μlを標的細胞とともに播種















　主要組織抗原が異なるマウス (B6 (H-2b) マウス，Balb/
c (H-2d) マウス) を用いて同種骨髄移植を施行した．WT 
Balb/c宿主マウスに計9.0 Gy (4.5 Gy×2回， 4時間間隔 ) 
の致死的全身放射線照射施行し，二酸化炭素にて犠死さ
せたWT B6ドナーマウスより採取した骨髄 (5x106) を尾
静脈より静脈内投与した．致死的なGVHDを誘導するた











Fig. 4.  Determination of the absolute numbers of DCs.
 Absolute number of host DCs (Gr-1－CD3－DX5－B220－, and CD11c＋) within the spleen was evaluated on day 5 after bone marrow 
transplantation (BMT) by counting chambers and flow cytometry. Within the total splenic mononuclear cells, 7AAD negative live cells 
were gated (A) for analysis. Among the live cells, H2-d positive host splenocyte were selected for further analysis (B). Within the host live 
splenocytes, lineage-negative (Gr-1－CD3－DX5－B220－) cells (C) were analyzed for the expression of CD11c (D). Total counts of CD11c＋ 
DCs were calculated from these data.
Fig. 3.  Transplantation model and evaluation of host DCs by flow 
cytometry.
 Lethally irradiated Balb/c (H-2d) hosts received BM cells from 
WT B6 (H-2b) together with splenocytes from WT B6, CIK cells 
from B6 or CIK cells from IFN-γ KO B6 at indicated doses. 





統計学的解析はGraphPad Prism ver.4.0 (Graphpad 













































Fig. 5.  Cytotoxic assay of CIK cells against DCs.
 51Cr release assay was performed to evaluate the cytotoxic 
activity of CIK cells against DCs. Both syngeneic (open 
circles) and allogeneic (closed circles) CIK cells showed 
significant killing activity against DCs. Allogeneic CIK cells 
exhibited significantly more killing activity at broad range of 
effector-target ratios than syngeneic CIK cells. Allogeneic CD8 
positive cells did not show any killing activity against DCs 
(data not shown). 
F ig . 6.  Reduc t ion o f hos t DCs induced by CIK ce l l 
transplantation.
 Splenic DC numbers were compared between days 1 and 3 
after BMT and compared among different BMT conditions. 
Compared to standard BMT model (closed circles, BM cells 
with splenocytes), DC numbers were significantly reduced 
when BMT was done with CIK cells (open circles). Closed 



























Fig. 7.  Effect of NKG2D blocking antibody.
 Role of NK cell surface antigen NKG2D in cytotoxic activity of allogeneic and syngeneic CIK cells was evaluated by adding neutralizing 
anti-NKG2D antibody in the killing assay. (A) Cytotoxic activity of B6 CIK was determined using Balb/c DC with (open circles) or without 
(closed circles) anti-NKG2D antibody. (B) Cytotoxic activity of B6 CIK was determined using B6 DC with (open circles) or without 
(closed circles) anti-NKG2D antibody. 
Fig. 8.  Cytotoxic assay of IFN-γ KO CIK cells against DCs.
 Killing activity of CIK derived from WT B6 (A, closed circles) was compared with CIK derived from IFN-γ KO mice (B, closed circles), 
using syngeneic DC as target cells. Killing activity of IFN-γ KO CIK cells was much less compared to that of WT CIK cells. Addition of 
anti-IFN-γ neutralizing antibody to the assay did not show any significant effect (A and B, open circles).
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Fig. 9.  Reduction of host DCs induced by IFN-γ KO CIK cells. 
 Splenic DC numbers were compared on day 5 after BMT 
among dif ferent BMT conditions. Compared with standard 
BMT model, splenic DC numbers were significantly reduced 
in the presence of WT CIK cells (p<0.05). This reduction was 
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Abstract
 Cytokine-induced killer (CIK) cells are ex vivo–expanded T lymphocytes expressing both natural killer (NK)- and 
T-cell markers. It was reported previously that adoptive transfer of allogeneic CIK cells in a murine model causes minimal 
graft-versus-host disease (GVHD) with retention of antitumor activity mediated by NKG2D, an activating receptor expressed 
on NK cells. The mechanism of suppression of GVHD by CIK cells is not fully understood. We examined whether allogeneic 
CIK cells suppress GVHD by eliminating host dendritic cells (DCs), and then whether interferon (IFN)-γ is involved in such 
suppression mechanisms. In the 51Cr release cytotoxicity assay, CIK cells showed strong cytotoxic activity against DCs 
generated from rodent bone marrow (BM) cells. This cytotoxic activity did not change with the addition of NKG2D blocking 
antibody, suggesting the involvement of mechanisms other than the NKG2D / NKG2D ligand system. Next, we showed that 
the killing activity of IFN-γ knockout (KO) CIK cells was decreased compared to that of wild-type (WT) CIK cells. To further 
explore the mechanism whereby IFN-γ KO CIK cells exhibit reduced killing activity against DCs, IFN-γ neutralizing 
antibody was added to the reaction mixture with WT CIK cells. However, the killing activity of WT CIK cells against DCs did 
not change with IFN-γ neutralizing antibody. These results suggested that IFN-γ itself does not affect killing activity, 
although IFN-γ is essential to the enhancement of killing activity during the ex vivo culture of CIK cells. Our next 
experiment addressed whether CIK cells eliminated host DCs in vivo. We compared the residual number of host-typed 
splenic DCs between mice receiving BM cells plus WT CIK cells and mice receiving BM cells plus IFN-γ KO CIK cells. The 
data showed that the number of host DCs in the spleen in mice receiving the WT CIK cells was significantly lower than that 
in mice receiving IFN-γ KO CIK cells. In conclusion, we propose that allogeneic CIK cells eliminate host DCs due to 
enhancement of killing activity by IFN-γ, leading to attenuation of GVHD.
